Homeβ€ΊBiologyβ€ΊGeneticsβ€ΊMutations
🧬 Full Lesson · Genetics
Point Β· Frameshift Β· Chromosomal
Mutations

Mutations are changes in DNA sequence β€” the ultimate source of all genetic variation and the cause of many diseases. Understanding mutations means understanding how cancers arise, why some genetic diseases are more severe than others, and how cells repair DNA damage to prevent the chaos that unchecked mutation would cause.

Types of Mutations
From single nucleotides to entire chromosomes

Mutations range in scale from a single base change to the addition or deletion of entire chromosomes. Their effects on protein function depend on where they occur, what they change, and whether the affected gene is critical for cell survival or function.

πŸ’‘ DNA Repair β€” The Cell's Mutation Defense Systems
Cells have multiple overlapping DNA repair systems that continuously scan for and fix DNA damage:

Base excision repair (BER): Repairs small base modifications (oxidized, deaminated, or alkylated bases). DNA glycosylase removes the damaged base β†’ AP endonuclease nicks the sugar-phosphate backbone β†’ DNA Pol fills the gap β†’ ligase seals.

Nucleotide excision repair (NER): Repairs bulky DNA lesions that distort the helix (UV-induced thymine dimers, chemical adducts). A large enzyme complex recognizes the distortion β†’ excises ~25–30 nucleotide patch around the lesion β†’ DNA Pol fills β†’ ligase seals. Xeroderma pigmentosum = inherited NER deficiency β†’ extreme UV sensitivity β†’ >1000Γ— elevated skin cancer risk.

Mismatch repair (MMR): Repairs base mismatches left after replication. Recognizes helical distortion from mismatched bases β†’ excises the newly synthesized strand β†’ resynthesizes. Lynch syndrome = inherited MMR deficiency β†’ microsatellite instability β†’ colorectal cancer.

Homologous recombination (HR) and non-homologous end joining (NHEJ): Repair double-strand breaks. HR (using the sister chromatid as template) is accurate; NHEJ is faster but error-prone. BRCA1/BRCA2 are essential for HR β€” their loss forces cells to use error-prone NHEJ, causing chromosomal instability.
Point
Point mutations β€” single nucleotide changes
Point mutations are changes at a single nucleotide position. Three types:

Silent (synonymous): The codon changes but specifies the same amino acid (due to genetic code degeneracy). No effect on protein sequence. Example: GUU β†’ GUC (both = valine). Most common type at the third codon position (wobble).

Missense: The codon changes and specifies a different amino acid. Effect depends on whether the amino acid change alters protein function. Conservative missense (chemically similar amino acid substitution) may be tolerable; nonconservative missense (different chemistry) often disrupts function. Sickle cell disease (Glu→Val in β-globin) = nonconservative missense.

Nonsense: A codon is changed to a stop codon (UAA, UAG, or UGA) β†’ premature termination β†’ truncated protein β†’ usually non-functional. Generally more severe than missense. Can cause nonsense-mediated mRNA decay (NMD) β€” the cell degrades mRNA with premature stop codons. Examples: many cases of Duchenne muscular dystrophy, Ξ²-thalassemia.
Memory trick: Silent = same amino acid (doesn't matter). Missense = different amino acid (may or may not matter). Nonsense = STOP codon too early = protein cut short (almost always matters). 'Nonsense stops sense.'
Frame
Frameshift mutations β€” insertions and deletions
Frameshift mutations are insertions or deletions of a number of nucleotides NOT divisible by 3. Because the genetic code is read in non-overlapping triplets from the AUG start codon, inserting or deleting 1 or 2 nucleotides shifts the reading frame β€” every codon downstream of the mutation is different β†’ completely different amino acid sequence β†’ usually a premature stop codon β†’ non-functional protein.

Insertions/deletions of 3 nucleotides (or multiples of 3) are in-frame mutations β€” they add or remove amino acids without changing the reading frame. These are often less severe (unless the deleted amino acid is critical). Ξ”F508 in CF = 3-nucleotide in-frame deletion.

Frameshifts are generally the most severe point-level mutations because they corrupt all downstream codons. Most DMD mutations are out-of-frame deletions affecting multiple exons.
Memory trick: Frameshift = not a multiple of 3 nucleotides deleted/inserted = reading frame SHIFTS = wrong amino acids from here on = usually a stop codon soon after = truncated protein. 'One or two = all wrong through.'
Chrom
Chromosomal mutations β€” large-scale rearrangements
Chromosomal mutations affect large segments of DNA or entire chromosomes:

Deletions: Loss of a chromosomal segment. Cri du chat syndrome (deletion of 5p) β†’ intellectual disability, characteristic high-pitched cry.
Duplications: A segment is duplicated. Charcot-Marie-Tooth disease type 1A = duplication of 17p12 (PMP22 gene β†’ extra copy β†’ demyelinating neuropathy).
Inversions: A segment is reversed. May disrupt genes at the breakpoints or alter gene regulation.
Translocations: A segment moves to a different chromosome. Reciprocal translocation between chromosomes 9 and 22 (Philadelphia chromosome, t(9;22)) fuses the BCR and ABL genes β†’ BCR-ABL fusion protein β†’ constitutively active tyrosine kinase β†’ CML.
Aneuploidy: Gain or loss of whole chromosomes. Trisomy 21 (Down syndrome), Turner syndrome (45,X), Klinefelter (47,XXY). Usually results from meiotic nondisjunction.
Memory trick: Philadelphia chromosome = t(9;22) = BCR-ABL = CML. Translocation = fusion gene = constitutively active kinase = cancer. Aneuploidy = nondisjunction = trisomy or monosomy.
πŸ”¬ Applied Scenario β€” Mutations in Cancer and Genetic Disease
Understanding mutation types explains the molecular basis of the most important genetic diseases:
A
KRAS G12V — oncogenic missense mutation. KRAS codon 12 normally encodes glycine (GGT). A G→T transversion at the first position changes GGT to GTT (glycine → valine). This nonconservative missense mutation eliminates GTPase activity from the Ras protein → Ras stays permanently in the GTP-bound (active) state → continuous MAPK pathway activation → uncontrolled proliferation. Found in ~95% of pancreatic cancers, ~40% of colorectal cancers, ~30% of lung adenocarcinomas. One amino acid change causes one of the most common cancer driver mutations.
B
Trinucleotide repeat expansions β€” Huntington's and fragile X. A unique class of mutation: unstable tandem repeat sequences that expand during replication. Huntington's disease: CAG repeat in HTT gene (normally 10–35 repeats; disease occurs with >36 repeats). CAG encodes glutamine β†’ polyglutamine tract in huntingtin protein β†’ protein misfolds and aggregates β†’ neuronal death in basal ganglia and cortex. Longer repeats β†’ earlier onset β†’ more severe. Anticipation (each generation more severe) results because the repeat tends to expand during transmission. Fragile X: CGG repeat in FMR1 5'UTR (normal <55; disease with >200 repeats) β†’ methylation of FMR1 promoter β†’ gene silenced β†’ no FMRP β†’ intellectual disability.
C
Transposons β€” 'jumping genes' as natural mutagens. Approximately 45% of the human genome is derived from transposable elements β€” DNA sequences that can copy themselves and insert elsewhere. New transposon insertions can disrupt genes (if inserted in exon) or alter gene regulation (if inserted near regulatory sequences). L1 retrotransposons (LINEs) are the most active in humans and have caused documented cases of inherited hemophilia, DMD, and cancer when they insert into critical genes. The cell normally silences transposons in germline cells via the piRNA pathway β€” failure of this silencing causes widespread mutagenesis.
D
Mutagen exposure and cancer risk. Chemical mutagens alter DNA bases: alkylating agents (nitrosamines in smoked food and cigarette smoke) add alkyl groups β†’ mispairing β†’ G-C to A-T transitions. Intercalating agents (acridine dyes) insert between base pairs β†’ frameshift mutations. UV light (pyrimidine dimers β†’ C-T or CC-TT transitions β€” the UV 'signature mutation'). Ionizing radiation (double-strand breaks β†’ chromosomal rearrangements). Each mutagen produces a characteristic pattern of mutations ('mutational signature') that can be detected in tumor genomes and attributed to specific exposures.
πŸ“Œ Exam Application
Mutation questions test types, effects, and repair mechanisms:

1. Point mutation types: Silent (same amino acid), Missense (different amino acid), Nonsense (premature stop). Sickle cell = missense. DMD nonsense mutations β†’ truncated dystrophin.

2. Frameshift: Insertion or deletion NOT divisible by 3 β†’ shifts reading frame β†’ wrong amino acids + usually premature stop. In-frame deletion (Γ·3) β†’ removes/adds amino acid without frame shift (Ξ”F508 in CF).

3. Chromosomal mutations: Deletion, duplication, inversion, translocation, aneuploidy. t(9;22) = Philadelphia chromosome = BCR-ABL = CML. Trisomy 21 = Down syndrome.

4. DNA repair systems: BER (small base damage), NER (bulky lesions/UV β€” XP when deficient), MMR (mismatches β€” Lynch syndrome when deficient), HR/NHEJ (double-strand breaks β€” BRCA1/2 for HR).

5. Trinucleotide repeats: Huntington's (CAG in HTT, >36 β†’ disease), Fragile X (CGG in FMR1, >200 β†’ methylation β†’ silencing).
⚠️ The Most Common Mutation Mistakes
Frameshift requires insertion or deletion NOT divisible by 3 β€” not just any insertion or deletion. Students sometimes say any insertion or deletion is a frameshift. A 3-nucleotide (or 6, 9, etc.) insertion/deletion is an in-frame mutation β€” it adds or removes a codon but does not shift the reading frame. Only insertions/deletions of 1, 2, 4, 5, 7, 8... nucleotides (not multiples of 3) cause frameshifts. The Ξ”F508 CF mutation is a 3-nucleotide deletion β€” it is an in-frame mutation, not a frameshift, which is why the protein is made (just misfolded).

Silent mutations are NOT always truly silent. Although silent mutations don't change the amino acid sequence, they can affect mRNA stability, splicing, translation rate (due to codon usage bias β€” some codons are translated faster than others), and protein folding (translation rate affects co-translational folding). 'Silent' is a historical oversimplification β€” 'synonymous' is the more accurate term, and synonymous mutations can have phenotypic effects.

Not all mutations are harmful. The vast majority of mutations in non-coding regions and synonymous mutations have no detectable phenotypic effect (neutral). Many mutations in coding regions are tolerated because the amino acid change is chemically conservative or the region is not critical for protein function. The small fraction of mutations that are harmful (or rarely, beneficial) are the ones selected for or against by natural selection.
βœ“ Quick Self-Test
1. What is the difference between a missense, nonsense, and silent mutation?
2. Why does a frameshift mutation typically produce a non-functional protein?
3. What is the Philadelphia chromosome and what cancer does it cause?
4. What DNA repair mechanism is defective in xeroderma pigmentosum?
5. What is a trinucleotide repeat expansion and give one disease example?

Answers:
1. Silent (synonymous): nucleotide change alters the codon but not the amino acid (due to degeneracy) β€” no change in protein sequence. Missense: nucleotide change alters the codon to specify a different amino acid β€” protein sequence changed, effect on function depends on the specific substitution. Nonsense: nucleotide change converts an amino acid codon to a stop codon (UAA, UAG, or UGA) β€” translation terminates prematurely β†’ truncated, usually non-functional protein.
2. The genetic code is read in non-overlapping triplets starting from the AUG start codon. Inserting or deleting nucleotides in a number not divisible by 3 shifts the reading frame for all codons downstream of the mutation β†’ completely different amino acid sequence from that point on β†’ typically a premature stop codon is soon encountered β†’ truncated protein that is almost always non-functional.
3. The Philadelphia chromosome results from a reciprocal translocation between chromosomes 9 and 22 β€” t(9;22) β€” which fuses the BCR gene from chromosome 22 with the ABL gene from chromosome 9, creating the BCR-ABL fusion oncogene. BCR-ABL encodes a constitutively active tyrosine kinase that drives uncontrolled myeloid cell proliferation. It is found in >95% of cases of chronic myeloid leukemia (CML) and is the target of imatinib (Gleevec).
4. Xeroderma pigmentosum (XP) results from deficiency in nucleotide excision repair (NER). NER normally recognizes and repairs bulky DNA lesions that distort the helix, including UV-induced pyrimidine dimers (thymine dimers). Without NER, UV-induced DNA damage accumulates → C→T and CC→TT transition mutations → patients have >1000× elevated risk of skin cancer and must avoid sunlight completely.
5. A trinucleotide repeat expansion is a mutation in which an unstable tandem repeat sequence abnormally expands beyond a threshold number of repeats during DNA replication. The expanded repeat disrupts gene function. Example: Huntington's disease β€” the CAG trinucleotide repeat in the HTT gene normally has 10–35 copies; expansion to >36 copies encodes an abnormally long polyglutamine tract in the huntingtin protein β†’ protein aggregation β†’ progressive neurodegeneration of the basal ganglia and cortex.
Next Lesson
Inheritance Patterns
β†’
 ← All Genetics Lessons